NEU 0.81% $12.25 neuren pharmaceuticals limited

The Whens and Whys of Top Biotech M&A Deals, page-63

  1. 2,486 Posts.
    lightbulb Created with Sketch. 877
    If Jon is saying they can't beat us to market and you don't believe him what does that say about your belief in company and Jon's integrity?

    I personally don't believe it is just posturing. I doubt he would make such a statement if it were untrue given someone with a vested interest and more knowledge than you could presumably publicly challenge that statement (with some kind of factual information vs a feeling you have).

    As a company, we just sat very close to a Ph3 so we are intimately aware of how to run one, even if we did not run the Rett Ph3. We also clearly have the necessary organisational contacts via Phelan McDermid Syndrome Foundation to plug in to communities/trial participants/centres of excellence etc and as stated prior, should we not wish to run it all internally there are many trial 'guns for hire' to assist eg https://mobius-cro.com/our-services/
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$12.25
Change
-0.100(0.81%)
Mkt cap ! $1.565B
Open High Low Value Volume
$12.20 $12.25 $12.02 $3.677M 302.0K

Buyers (Bids)

No. Vol. Price($)
1 1579 $12.21
 

Sellers (Offers)

Price($) Vol. No.
$12.26 1199 1
View Market Depth
Last trade - 16.10pm 01/11/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.